# Remedy Meds reviews (2026): GLP-1 telehealth sellers | This GLP

A four-week fill billed monthly, and no figure a reader can see before the quiz.

Publisher: This GLP Editorial Team
Canonical: https://thisglp.com/reviews/remedy-meds
Updated: 2026-10-28

By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 Four-week fill, price behind a quiz

# Remedy Meds review

A four-week fill billed monthly, and no figure a reader can see before the quiz.

## The verdict

Remedy Meds sells compounded semaglutide and tirzepatide, but its public pages print no price for either. Every start button leads to a quiz that asks for height and weight first.

**Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures).

Category

GLP-1 telehealth

Molecule

Semaglutide · Tirzepatide

Form

Injection

Prescription

Required

Compounded

Yes — not FDA-approved

Remedy Meds sells both molecules by injection, plus a microdose line and a name-brand option. The homepage lists prepaid plans alongside month-to-month billing.

1.  ## Who writes the prescription, and what do they see?
    
    A prescription precedes shipping. The pages describe plans and tiers. The clinician is not described anywhere a reader can reach.
    
    The homepage reads "Month-to-month · Cancel anytime · HSA/FSA accepted" and "No Memberships or Hidden Fees". Each fill is a four-week supply, so a year holds thirteen fills rather than twelve.
    
2.  ## What happens when the dose goes up?
    
    The quiz's second screen reads "Your dose depends on your body." Nothing public states what the charge does at a higher dose. The microdose line is a separate product, not a lower rung.
    
3.  ## What the price includes
    
    No figure appears on the homepage, even with every FAQ opened. The start buttons for semaglutide, tirzepatide, microdose and name brand all open the same quiz. A monthly charge, whenever it is shown, buys four weeks, not a calendar month.
    
4.  ## What it claims, and what it cites
    
    Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named.
    

## Where it holds up, and where it does not

-   Strength: Month-to-month billing is stated
-   Strength: No membership fee is claimed
-   Strength: Pays from HSA or FSA funds
-   Limitation: No price before the quiz
-   Limitation: The quiz asks for body measurements first
-   Limitation: Thirteen fills a year, not twelve
-   Limitation: No state coverage list is recorded

## What the evidence says about this kind of treatment

The assessment above is about Remedy Meds. These are about the drugs it sells, and they are traced to the primary literature.

-   [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1)
-   [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1)
-   [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain)

Right for

A reader willing to finish the quiz who will count thirteen fills a year.

Wrong for

A reader who wants a published price before giving out health details.

## The evidence behind what Remedy Meds prescribes

These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.

-   [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review)
    
    A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
    
-   [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better)
    
    In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
    

## How Remedy Meds compares

| Seller | Who it suits | Go |
| --- | --- | --- |
| Prime Health | Readers who count charges rather than months |  |
| RestorLife Med | Readers who want monitoring included rather than billed separately |  |
| Revive Meds | Readers who want to buy one order at a time and will get the price in writing |  |

[Compare all providers side by side →](https://thisglp.com/best)

More GLP-1 telehealth sellers reviews: [FormBlends](https://thisglp.com/reviews/formblends) [FormidableMD](https://thisglp.com/reviews/formidablemd) [Framework](https://thisglp.com/reviews/framework) [Fresh Day Meds](https://thisglp.com/reviews/fresh-day) [Freya Meds](https://thisglp.com/reviews/freya-meds) [Fridays](https://thisglp.com/reviews/fridays)

Sponsored alternative

SkinnyRx

Readers choosing tirzepatide, the one line with a published standing rate

## Frequently asked

Is a price shown before the quiz?

No. The public pages print none, and any figure appears only inside the quiz.

Is a monthly charge a calendar month?

No. Each fill is a four-week supply, so a year of monthly billing is thirteen fills.

What is the microdose line?

A separate lower-dose product with its own start button, not a lower rung of the standard plan.

Or [compare every seller we cover](https://thisglp.com/best).

**Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).
